Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging.
Applications in this round must relate to one of the following disease(s): PD, PSP, DLB, MSA, AD, FTD, MCI, and vascular contributions and prodromes to the listed diseases.
Funding Available: $200,000 to $1,500,000 over up to 3 years.
No preliminary data is required; instead it can be collected as an initial milestone with well defined, quantifiable go/no-go criteria. The structure of the project and budget should match the quality of the preliminary data.
Project Eligibility: Project must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination of the above to help accelerate the development of therapeutics for neurodegenerative diseases of aging.